ORCID Profile
0000-0002-4101-5343
Current Organisations
Royal Children's Hospital
,
Deakin University
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Publisher: Magnolia Press
Date: 28-01-2022
DOI: 10.11646/ZOOTAXA.5093.4.3
Abstract: The type of the xeniid soft coral Sansibia flava (May, 1898) is re-described for the first time and its morphological diagnosis is presented. A subsequent integrated analysis of molecular and morphological characters of related Xeniidae, including species indigenous to the Indo-Pacific Ocean and invasive in the Atlantic (Brazil), led to the description of a new Sansibia species, as well as two new genera comprising an additional three new species. All of these taxa are encrusting, with polyps arising directly from a spreading basal membrane. Molecular phylogenetic analyses show that these genera are not sister taxa, thus further emphasizing the remarkable phylogenetic ersity of xeniids with such a growth form. The sclerites of all species are uniformly ellipsoid platelets, abundant throughout the colony. The species exhibit restricted, non-overlapping geographic ranges, with distinct genotypes (molecular operational taxonomic units) found in different marine realms. The results emphasize the importance of re-examination of original old type material while applying molecular phylogenetic analyses in order to delineate species boundaries and to recognize bio ersity patterns.
Publisher: SAGE Publications
Date: 29-08-2023
Publisher: Wiley
Date: 28-01-2019
DOI: 10.1111/EIP.12775
Abstract: Neuropsychiatric disorders including depression, bipolar and schizophrenia frequently exhibit a neuroprogressive course from prodrome to chronicity. There are a range of agents exhibiting capacity to attenuate biological mechanisms associated with neuroprogression. This review will update the evidence for putative neuroprotective agents including clinical efficacy, mechanisms of action and limitations in current assessment tools, and identify novel agents with neuroprotective potential. Data for this review were sourced from online databases PUBMED, Embase and Web of Science. Only data published since 2012 were included in this review, no data were excluded based on language or publication origin. Each of the agents reviewed inhibit one or multiple pathways of neuroprogression including: inflammatory gene expression and cytokine release, oxidative and nitrosative stress, mitochondrial dysfunction, neurotrophin dysregulation and apoptotic signalling. Some demonstrate clinical efficacy in preventing neural damage or loss, relapse or cognitive/functional decline. Agents include: the psychotropic medications lithium, second generation antipsychotics and antidepressants other pharmacological agents such as minocycline, aspirin, cyclooxygenase-2 inhibitors, statins, ketamine and alpha-2-delta ligands and others such as erythropoietin, oestrogen, leptin, N-acetylcysteine, curcumin, melatonin and ebselen. Signals of evidence of clinical neuroprotection are evident for a number of candidate agents. Adjunctive use of multiple agents may present a viable avenue to clinical realization of neuroprotection. Definitive prospective studies of neuroprotection with multimodal assessment tools are required.
Publisher: SAGE Publications
Date: 06-09-2021
DOI: 10.1177/10398562211037335
Abstract: To identify all past publications from Australasian Psychiatry with subject matter particularly relevant for trainees. The results of such a search could then be collated into an easily accessible resource available to trainees and their supervisors. An electronic search of the journal’s back catalogue was conducted. Eighty-seven articles published on subjects particularly relevant for trainees were discovered from within Australasian Psychiatry. In particular, multiple useful resources were identified on the topics of the scholarly project and formulation skills. Australasian Psychiatry has published a wealth of literature that is likely to be of significant benefit for trainees as they work their way through the Royal Australian and New Zealand College of Psychiatrists training programme.
Publisher: SAGE Publications
Date: 13-02-2023
Publisher: SAGE Publications
Date: 17-04-2022
Location: Australia
No related grants have been discovered for Oliver Robertson.